Richard Lake
机构: Professor University of Western Australia
每年引用次数
引用次数
引用: 12,964
H-指数: 53
I10-指数 : 108
出版物: 209
Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment
Rachael M. Zemek , Emma De Jong , Wee Loong Chin , Iona S. Schuster
Science Translational Medicine 11 ( 501)
129
2019
Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy.
Rachael M. Zemek , Wee Loong Chin , Anna K. Nowak , Michael J. Millward
Frontiers in Immunology 11 223 -223
18
2020
Induction of Tumor Cell Apoptosis In Vivo Increases Tumor Antigen Cross-Presentation, Cross-Priming Rather than Cross-Tolerizing Host Tumor-Specific CD8 T Cells
Anna K. Nowak , Richard A. Lake , Amanda L. Marzo , Bernadette Scott
Journal of Immunology 170 ( 10) 4905 -4913
498
2003
Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity
Amanda L. Marzo , Beverley F. Kinnear , Richard A. Lake , Jeffrey J. Frelinger
Journal of Immunology 165 ( 11) 6047 -6055
312
2000
New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents.
Anna K. Nowak , Richard A. Lake , Hedy Lee Kindler , Bruce W.S. Robinson
Seminars in Oncology 29 ( 1) 82 -96
116
2002
Peripheral CD8+ T cell proliferation is prognostic for patients with advanced thoracic malignancies
Melanie J. McCoy , Anna K. Nowak , Robbert G. van der Most , Ian M. Dick
Cancer Immunology, Immunotherapy 62 ( 3) 529 -539
19
2013
Cranking the Immunologic Engine with Chemotherapy: Using Context to Drive Tumor Antigen Cross-Presentation towards Useful Antitumor Immunity
Robbert G. van der Most , Andrew Currie , Bruce W.S. Robinson , Richard A. Lake
Cancer Research 66 ( 2) 601 -604
80
2006
Partial, but not Complete, Tumor-Debulking Surgery Promotes Protective Antitumor Memory when Combined with Chemotherapy and Adjuvant Immunotherapy
Steve Broomfield , Andrew Currie , Robbert G. van der Most , Matthew Brown
Cancer Research 65 ( 17) 7580 -7584
60
2005
The use of agonistic anti-CD40 therapy in treatments for cancer
Andrea Khong , Delia J. Nelson , Anna K. Nowak , Richard A. Lake
International Reviews of Immunology 31 ( 4) 246 -266
52
2012
Degeneracy of T cell receptor recognition of an influenza virus hemagglutinin epitope restricted by HLA-DQ and -DR class II molecules
Claerwen M. Jones , Richard A. Lake , Jonathan R. Lamb , Alex Faith
European Journal of Immunology 24 ( 5) 1137 -1142
19
1994
Cutting Edge: Tumor-Specific CTL Are Constitutively Cross-Armed in Draining Lymph Nodes and Transiently Disseminate to Mediate Tumor Regression following Systemic CD40 Activation
Philip A. Stumbles , Robyn Himbeck , Jeffrey A. Frelinger , Edward J. Collins
Journal of Immunology 173 ( 10) 5923 -5928
54
2004
Effect of NSAIDS and COX-2 inhibitors on the incidence and severity of asbestos-induced malignant mesothelioma: Evidence from an animal model and a human cohort
Cleo Robinson , Helman Alfonso , Samantha Woo , Nola Olsen
Lung Cancer 86 ( 1) 29 -34
11
2014
Bilateral murine tumor models for characterizing the response to immune checkpoint blockade.
Rachael M. Zemek , Vanessa S. Fear , Cath Forbes , Emma de Jong
Nature Protocols 15 ( 5) 1628 -1648
17
2020
Gemcitabine Exerts a Selective Effect on the Humoral Immune Response Implications for Combination Chemo-immunotherapy
Anna K Nowak , Bruce W S Robinson , Richard A Lake
Cancer Research 62 ( 8) 2353 -2358
200
2002
Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors.
Anna K Nowak , Bruce W S Robinson , Richard A Lake
Cancer Research 63 ( 15) 4490 -4496
479
2003
A phase 1b clinical trial optimizing regulatory T cell depletion in combination with platinum-based chemotherapy in thoracic cancers.
Tarek Meniawy , Tarek Meniawy , Alison McDonnell , Anna K Nowak
Expert Review of Anticancer Therapy 21 ( 5) 465 -474
2021
Malignant Pleural Effusions-A Window Into Local Anti-Tumor T Cell Immunity?
Anna K Nowak , Jonathan Chee , Richard A Lake , Nicola Principe
Frontiers in Oncology 11 672747 -672747
2021
Chemotherapy and immunotherapy: Mapping the road ahead
Alistair M Cook , W Joost Lesterhuis , Anna K Nowak , Richard A Lake
Current Opinion in Immunology 39 23 -29
113
2016
Immunogenic anti-cancer chemotherapy as an emerging concept
Nicole M Haynes , Robbert G van der Most , Richard A Lake , Mark J Smyth
Current Opinion in Immunology 20 ( 5) 545 -557
124
2008
Private specificities can dominate the humoral response to self-antigens in patients with cryptogenic fibrosing alveolitis
Cleo Robinson , Marinella Callow , Sandra Stevenson , Bruce WS Robinson
Respiratory Research 2 ( 2) 119 -124
14
2001